LECONASIA
Skip to content
  • Home
  • About
  • Testimonials
  • News
  • Contact

Local biotech firms poised to benefit from rosy venture capital outlook for 2021 – Crain’s New York Business

Posted on December 30, 2020 by admin
Local biotech firms poised to benefit from rosy venture capital outlook for 2021  Crain’s New York Business
Bookmark the permalink.

Post navigation

← Yet Another Year of Venture Capital Being Really White – WIRED
Venture capital firm Palm Drive Capital opens Miami office – South Florida Business Journal – South Florida Business Journal →

Recent Posts

  • How African startups raised venture capital in 2022 – TechCrunch
  • ‘Most active investor’ FJ Labs closes on $260M across two new funds – TechCrunch
  • Kenya’s growth was strongest in Africa’s VC market; clean tech, e-commerce pulled in most of the funding – TechCrunch
  • These Venture Veterans Have Launched A $350 Million Fund Aimed At Digitizing Life Sciences – Forbes
  • Creating a new dimension: Biotech VC merging tech and life sciences unveils with $350M – FierceBiotech
  • VC Salaries Data: How Much Employees in Platform Roles Get Paid – Business Insider
  • Venture capital investments into blockchain continue to free-fall: Report – Cointelegraph
  • Chemical giant Denka dives into VC with $100M fund managed by Pegasus Tech Ventures – TechCrunch
  • The 13 VCs dominating cybersecurity investing – Fortune
  • The rise of venture debt: When biotechs should—and shouldn’t—use it – FierceBiotech
Singapore Office:
21 Bukit Batok Crescent
#09-79 WCEGA Tower
Singapore 658065
Korea Office:
1432 Seocho LG Eclat Banpo-daero
14-gil 71, Seocho-gu Seoul,
Republic of Korea
For Regional Support:
support@leconasia.com

For Sales & Marketing:
sales@leconasia.com

LECON ASIA
Copyrights © 2015
All Rights Reserved

www.leconasia.com

Zerif Lite developed by ThemeIsle